A recent study from the lab of the Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease.
The U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.
Karen Lawrence works to understand the connection between PTSD and dementia, analyzing data from 42 Alzheimer’s Disease Research Centers across the U.S.
A Sanders-Brown Center on Aging project will focus on how genetic factors contribute to dementia. The work was recently awarded funding from the National Institute on Aging that will total more than $1.7 million.
The first published work coming from a multi-million-dollar grant received last year by a team from UK recently made the cover of the Journal of Neuroscience.
This is a free event for older adults to explore interactive booths, free health and memory screenings, and presentations on HEALTHY AGING! Lunch will be provided. Registration is not required.
48th Annual Naff Symposium
04/21/2023 - 08:00 am - 04/21/2023 - 04:30 pm
W.T. Young Library Auditorium
Agenda, featured speakers and more information here.
Throughout March, UK is spotlighting Women Making History. These women are leading their fields of research and impacting the lives of Kentuckians. For Allison Gibson, Ph.D., her passion is helping some of the most vulnerable Kentuckians.
The Pat Summitt Foundation presented a $25,000 grant to UK's Sanders-Brown Center on Aging during the UK women’s basketball game against Auburn on January 26, 2023.
